The list includes closures that took place in 2025 in Adams, Berks, Cumberland, Dauphin, Franklin, Lancaster, Lebanon, Mifflin, Northumberland, Perry, Schuylkill, Snyder and York counties.

Fans of the Knives Out series have been eagerly awaiting the latest installment, Wake Up Dead Man: A Knives Out Mystery, and the film does not disappoint. With its intricate plot and a myriad of ...

Third Person Shooters Arc Raiders GOTY advocate and former FPS pro Shroud threatens to quit the game due to cheaters Third Person Shooters Embark lowers Arc Raiders blueprint drop rate after setting ...

Shane Limbaugh (He/Him) is a Contributor from the US. While he hasn't been writing about games for very long he has certainly been playing them. His degree in Game Design and Criticism let him better ...

Blueprints for Addiction Recovery, Inc. is opening a community drop-in center in Lancaster city on Wednesday. The Lancaster Recovery Center will provide services for families, individuals and ...

Squarespace wants you to build a website with AI. Its Blueprint AI Builder feature began life as a guided website design system in 2023, but, like many things these days, it was revamped with ...

The premise of Marcus du Sautoy’s Blueprints: How Mathematics Shapes Creativity is that mathematics and creativitiy spring from the same well — structure. Individual numbers exist without human help.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Kwan Wei Kevin Tan Every time Kwan Wei Kevin Tan publishes a story, you’ll get an alert ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Sanofi said Monday it plans to buy Blueprint Medicines in a deal ...

Sanofi has agreed to acquire Blueprint Medicines for up to approximately $9.5 billion, the companies said today, in a deal designed to expand the buyer’s rare immunological disease portfolio with an ...